Pfizer Research and Development Expenses 2010-2024 | PFE

Pfizer research and development expenses for the twelve months ending September 30, 2024 were $10.602B, a 7.65% decline year-over-year.

  • Pfizer annual research and development expenses for 2023 were $10.679B, a 6.55% decline from 2022.
  • Pfizer annual research and development expenses for 2022 were $11.428B, a 10.31% increase from 2021.
  • Pfizer annual research and development expenses for 2021 were $10.36B, a 18.96% increase from 2020.

Pfizer Research and Development Expenses 2010-2024 | PFE

  • Pfizer annual research and development expenses for 2023 were $10.679B, a 6.55% decline from 2022.
  • Pfizer annual research and development expenses for 2022 were $11.428B, a 10.31% increase from 2021.
  • Pfizer annual research and development expenses for 2021 were $10.36B, a 18.96% increase from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$757B
Novo Nordisk (NVO)$483B
Johnson & Johnson (JNJ)$377.3B
AbbVie (ABBV)$354.3B
Merck (MRK)$255.9B
Novartis AG (NVS)$218.9B
AstraZeneca (AZN)$200.6B
Sanofi (SNY)$131.3B
Innoviva (INVA)$1.3B